Literature DB >> 29909816

Seroepidemiology of varicella zoster virus infection in Vojvodina, Serbia.

S Medić1, V Petrović1, V Milosević1, Z Lozanov-Crvenković2, S Brkić3, N Andrews4, F de Ory5, C Anastassopoulou6.   

Abstract

The present cross-sectional serosurvey constitutes the first effort to describe the varicella zoster virus (VZV) seroepidemiology in Serbia. An age-stratified serum bank of 3570 residual samples collected between 2015 and 2016 in each of the seven districts of the Vojvodina Province was tested for IgG anti-VZV antibodies with an enzyme immunoassay. Results were standardised into common units according to the European Sero-Epidemiology Network (ESEN2) methodology. Univariable and multivariable analyses were used to examine the relationships between standardised anti-VZV positivity or logarithmically transformed antibody titres and demographic features of study subjects. Seropositivity (85% overall) increased with age, in parallel with geometric mean titres. By the time of school entry, 68% of children were immune. The slower subsequent acquisition of immunity leaves epidemiologically relevant proportions of adolescents (7%), young adults (6%) and especially females of reproductive age (6%) prone to more severe forms of varicella. In the ongoing pre-vaccine era, natural infection provides a high level of collective immunity, with the highest VZV transmission in children of preschool age. The detected gaps in VZV immunity of the Serbian population support the adoption of the official recommendations for varicella immunisation of non-immune adolescents and young adults, including non-pregnant women of childbearing age.

Entities:  

Keywords:  Antibodies to varicella zoster virus (anti-VZV); ESEN2; Europe; chickenpox; seroprevalence; standardisation; vaccines and immunisation

Mesh:

Year:  2018        PMID: 29909816      PMCID: PMC9507937          DOI: 10.1017/S0950268818001619

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  16 in total

1.  A random cluster survey and a convenience sample give comparable estimates of immunity to vaccine preventable diseases in children of school age in Victoria, Australia.

Authors:  Heath Kelly; Michaela A Riddell; Heather F Gidding; Terry Nolan; Gwendolyn L Gilbert
Journal:  Vaccine       Date:  2002-08-19       Impact factor: 3.641

2.  [Detection of antibodies to cytomegaloviruses, herpes simplex viruses and varicella-zoster viruses in persons positive for human immunodeficiency virus antibodies].

Authors:  N Kuljić-Kapulica; V Zivanović-Marinković; A Sarić; M Djokić
Journal:  Srp Arh Celok Lek       Date:  1989 Jul-Aug       Impact factor: 0.207

3.  Varicella and herpes zoster vaccines: WHO position paper, June 2014.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2014-06-20

Review 4.  Varicella vaccination: a laboured take-off.

Authors:  P Carrillo-Santisteve; P L Lopalco
Journal:  Clin Microbiol Infect       Date:  2014-05       Impact factor: 8.067

5.  The seroepidemiology of varicella in Italy.

Authors:  G Gabutti; C Penna; M Rossi; S Salmaso; M C Rota; A Bella; P Crovari
Journal:  Epidemiol Infect       Date:  2001-06       Impact factor: 2.451

6.  European seroepidemiology network 2: Standardisation of assays for seroepidemiology of varicella zoster virus.

Authors:  Fernando de Ory; José Manuel Echevarría; George Kafatos; Cleo Anastassopoulou; Nick Andrews; Josephine Backhouse; Guy Berbers; Blazena Bruckova; Daniel I Cohen; Hester de Melker; Irja Davidkin; Giovanni Gabutti; Louise M Hesketh; Kari Johansen; Sari Jokinen; Lindsay Jones; Anika Linde; Elisabeth Miller; Joël Mossong; Anthony Nardone; Maria Cristina Rota; Andreas Sauerbrei; François Schneider; Zahava Smetana; Annedore Tischer; Athanassios Tsakris; Robert Vranckx
Journal:  J Clin Virol       Date:  2006-04-17       Impact factor: 3.168

Review 7.  Pathogenesis and current approaches to control of varicella-zoster virus infections.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

8.  Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Mona Marin; Dalya Güris; Sandra S Chaves; Scott Schmid; Jane F Seward
Journal:  MMWR Recomm Rep       Date:  2007-06-22

9.  The epidemiology of Varicella Zoster Virus infection in Italy.

Authors:  Giovanni Gabutti; Maria C Rota; Marcello Guido; Antonella De Donno; Antonino Bella; Marta L Ciofi degli Atti; Pietro Crovari
Journal:  BMC Public Health       Date:  2008-10-27       Impact factor: 3.295

Review 10.  Varicella vaccination in Europe - taking the practical approach.

Authors:  Paolo Bonanni; Judith Breuer; Anne Gershon; Michael Gershon; Waleria Hryniewicz; Vana Papaevangelou; Bernard Rentier; Hans Rümke; Catherine Sadzot-Delvaux; Jacques Senterre; Catherine Weil-Olivier; Peter Wutzler
Journal:  BMC Med       Date:  2009-05-28       Impact factor: 8.775

View more
  3 in total

1.  Declining seroprevalence of hepatitis A in Vojvodina, Serbia.

Authors:  Snežana Medić; Cleo Anastassopoulou; Vesna Milošević; Nataša Dragnić; Smiljana Rajčević; Mioljub Ristić; Vladimir Petrović
Journal:  PLoS One       Date:  2019-06-04       Impact factor: 3.240

2.  Sero-epidemiological study in prediction of the risk groups for measles outbreaks in Vojvodina, Serbia.

Authors:  Mioljub Ristić; Vesna Milošević; Snežana Medić; Jelena Djekić Malbaša; Smiljana Rajčević; Jasmina Boban; Vladimir Petrović
Journal:  PLoS One       Date:  2019-05-09       Impact factor: 3.240

3.  Detection of Circulating VZV-Glycoprotein E-Specific Antibodies by Chemiluminescent Immunoassay (CLIA) for Varicella-Zoster Diagnosis.

Authors:  Arnaud John Kombe Kombe; Jiajia Xie; Ayesha Zahid; Huan Ma; Guangtao Xu; Yiyu Deng; Fleury Augustin Nsole Biteghe; Ahmed Mohammed; Zhao Dan; Yunru Yang; Chen Feng; Weihong Zeng; Ruixue Chang; Keyuan Zhu; Siping Zhang; Tengchuan Jin
Journal:  Pathogens       Date:  2022-01-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.